C12N 2760/18051
Methods of production or purification of viral material
C12N2760/18051 (Methods of production or purification of viral material) appears on 12 US grants and 12 published applications in this corpus.
Search patents in C12N- Granted patents
- 12
- Published applications
- 12
- Assignees
- 19
- Inventors
- 41
- Latest grant
- 29 Mar 2022
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1978 | 1 | 0 |
| 1979 | 0 | 0 |
| 1980 | 0 | 0 |
| 1981 | 0 | 0 |
| 1982 | 0 | 0 |
| 1983 | 0 | 0 |
| 1984 | 0 | 0 |
| 1985 | 0 | 0 |
| 1986 | 0 | 0 |
| 1987 | 0 | 0 |
| 1988 | 0 | 0 |
| 1989 | 0 | 0 |
| 1990 | 0 | 0 |
| 1991 | 0 | 0 |
| 1992 | 0 | 0 |
| 1993 | 1 | 0 |
| 1994 | 0 | 0 |
| 1995 | 0 | 0 |
| 1996 | 0 | 0 |
| 1997 | 0 | 0 |
| 1998 | 0 | 0 |
| 1999 | 0 | 0 |
| 2000 | 0 | 0 |
| 2001 | 0 | 0 |
| 2002 | 0 | 0 |
| 2003 | 0 | 0 |
| 2004 | 0 | 0 |
| 2005 | 0 | 1 |
| 2006 | 0 | 0 |
| 2007 | 0 | 0 |
| 2008 | 0 | 0 |
| 2009 | 0 | 0 |
| 2010 | 0 | 1 |
| 2011 | 0 | 0 |
| 2012 | 1 | 0 |
| 2013 | 0 | 1 |
| 2014 | 0 | 0 |
| 2015 | 0 | 0 |
| 2016 | 0 | 1 |
| 2017 | 0 | 0 |
| 2018 | 1 | 1 |
| 2019 | 2 | 3 |
| 2020 | 3 | 0 |
| 2021 | 2 | 0 |
| 2022 | 1 | 1 |
| 2023 | 0 | 0 |
| 2024 | 0 | 0 |
| 2025 | 0 | 3 |
By publication year. Applications have been published since 2001.
Subgroups
Granted patents
Recent patents
- Heat-resistant recombinant Newcastle Disease Virus vaccine strain capable of expressing truncated Fiber 2 protein of Fowl Adenovirus serotype 4, preparation method and application thereof29 Mar 2022US 11,285,206 B2Institute of Animal Husbandry and Veterinary Sciences, Hubei Academy of Agricultural Sciences
- Recombinant Zika vaccines7 Sep 2021US 11,110,162 B2Themis Bioscience GmbH
- Chromatography based purification strategies for viruses19 Jan 2021US 10,894,079 B2Themis Bioscience GmbH
- Bioreactor production of virus from adherent cells1 Dec 2020US 10,851,350 B1Genelux Corporation
- Method for vacuum-assisted preservation of biologics including vaccines19 May 2020US 10,653,627 B2Boehringer Ingelheim Animal Health USA Inc.
- A process for storing biologically active constructs in a biodegradable material10 Jul 2025US 2025/0223571 A1Bioneedle Drug Delivery B.V.
- Viral vectors3 Jul 2025US 2025/0213674 A1City, University of London
- Recombinant live attenuated rsv vaccine strain and production method therefor24 Apr 2025US 2025/0127872 A1SK Bioscience Co., Ltd.
- Heat-resistant recombinant newcastle disease virus vaccine strain capable of expressing truncated fiber 2 protein of fowl adenovirus serotype 4, preparation method and application thereof24 Feb 2022US 2022/0054626 A1Institute of Animal Husbandry and Veterinary Sciences, Hubei Academy of Agricultural Sciences
- Recombinant zika vaccines21 Mar 2019US 2019/0083601 A1Themis Bioscience GmbH
Most cited
By later US patents
- Method of propagating human paramyxoviruses using continuous cell lines17US 5,262,359 AThe United States of America, as represented by the Secretary, Dept. of HHS · 1993
- Chromatography based purification strategies for viruses10US 10,894,079 B2Themis Bioscience GmbH · 2021
- Methods for the prevention of aggregation of viral components6US 10,080,793 B2De Staat Der Nederlanden, Vert.Door De Minister Van Vws, Ministerie Van Volksgezonheid, Welzijn En Sport · 2018
- Canine lung cell strain culture systems and processes for the cultivation of viruses and vaccines therefrom5US 4,112,068 ACutter Laboratories, Inc. · 1978
- Methods for producing an active constituent of a pharmaceutical or a diagnostic agent in an MDCK cell suspension culture3US 10,329,536 B2Seqirus UK Limited · 2019